Recombinant Human FCRL6 protein (His tag) is a Human Fragment protein, in the 20 to 307 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE.
>90% SDS-PAGE
Escherichia coli
His tag N-Terminus
SDS-PAGE
No
L Y L Q A W P N P V F E G D A L T L R C Q G W K N T P L S Q V K F Y R D G K F L H F S K E N Q T L S M G A A T V Q S R G Q Y S C S G Q V M Y I P Q T F T Q T S E T A M V Q V Q E L F P P P V L S A I P S P E P R E G S L V T L R C Q T K L H P L R S A L R L L F S F H K D G H T L Q D R G P H P E L C I P G A K E G D S G L Y W C E V A P E G G Q V Q K Q S P Q L E V R V Q A P V S R P V L T L H H G P A D P A V G D M V Q L L C E A Q R G S P P I L Y S F Y L D E K I V G N H S A P C G G T T S L L F P V K S E Q D A G N Y S C E A E N S V S R E R S E P K K L S L K G S Q V L F T P A S N W
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Acts as a MHC class II receptor (PubMed:20519654). When stimulated on its own, does not play a role in cytokine production or the release of cytotoxic granules by NK cells and cytotoxic CD8(+) T cells (PubMed:17213291, PubMed:18991291). Does not act as an Fc receptor (PubMed:18991291).
Fc receptor-like protein 6, FcR-like protein 6, FcRL6, Fc receptor homolog 6, IFGP6, FcRH6, FCRL6, FCRH6
Recombinant Human FCRL6 protein (His tag) is a Human Fragment protein, in the 20 to 307 aa range, expressed in Escherichia coli, with >90% purity and suitable for SDS-PAGE.
>90% SDS-PAGE
Escherichia coli
His tag N-Terminus
SDS-PAGE
No
No
Human
pH: 7.2 - 7.4
Constituents: Tris buffer, 50% Glycerol (glycerin, glycerine)
L Y L Q A W P N P V F E G D A L T L R C Q G W K N T P L S Q V K F Y R D G K F L H F S K E N Q T L S M G A A T V Q S R G Q Y S C S G Q V M Y I P Q T F T Q T S E T A M V Q V Q E L F P P P V L S A I P S P E P R E G S L V T L R C Q T K L H P L R S A L R L L F S F H K D G H T L Q D R G P H P E L C I P G A K E G D S G L Y W C E V A P E G G Q V Q K Q S P Q L E V R V Q A P V S R P V L T L H H G P A D P A V G D M V Q L L C E A Q R G S P P I L Y S F Y L D E K I V G N H S A P C G G T T S L L F P V K S E Q D A G N Y S C E A E N S V S R E R S E P K K L S L K G S Q V L F T P A S N W
Fragment
35.7 kDa
20 to 307
Recombinant
His tag N-Terminus
Liquid
Acts as a MHC class II receptor (PubMed:20519654). When stimulated on its own, does not play a role in cytokine production or the release of cytotoxic granules by NK cells and cytotoxic CD8(+) T cells (PubMed:17213291, PubMed:18991291). Does not act as an Fc receptor (PubMed:18991291).
Phosphorylated on Tyr residues. Tyrosine phosphorylation induces association with phosphatase PTPN11, PTPN6, INPP5D, INPPL1 and GRB2.
Blue Ice
-20°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
This supplementary information is collated from multiple sources and compiled automatically.
FCRL6 also known as Fc receptor-like protein 6 is a transmembrane receptor expressed primarily on cytotoxic T cells and NK cells. This protein has a mass of approximately 55 kDa. It is predominantly expressed in immune tissues such as the spleen and tonsils and its expression is mainly found in T cell subsets. FCRL6 contains an immunoglobulin-like extracellular domain that plays an important role in the immune cell interactions.
FCRL6 is involved in regulating immune response and cytotoxic activity. This protein interacts with MHC class II molecules indicating its potential role in antigen presentation and immune system modulation. FCRL6 does not typically form part of a larger protein complex but it may engage with other cell surface molecules for its biological function.
FCRL6 participates in immune signaling pathways that regulate T cell and NK cell activation. These pathways often involve interactions driven by integrin and non-integrin proteins that modulate immune effector functions. Related proteins in the pathway include other members of the Fc receptor-like family which exhibit varying roles in immune modulation and maintenance of immune tolerance.
FCRL6 has been associated with autoimmune conditions and certain cancers. In autoimmune diseases such as rheumatoid arthritis dysregulation of FCRL6 expression has been noted impacting T cell activity. In some cancers irregular FCRL6 expression has been linked to altered immune cell function. Additionally FCRL6's interaction with other immune regulatory proteins such as PD-1 further connects it to cancer immunology and potential therapeutic targeting.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) analysis of ab225642 with 5% enrichment gel and 15% separation gel.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com